MAPT and Alzheimer disease: Taken together, these findings suggest that MAPT mutations may directly affect mitochondrial function and dynamics, and thereby may constitute a key event in AD pathogenesis by causing a deficit in respiratory complex activity, and by leading to mitochondrial fragmentation, both of which are characteristic of the breakdown of neuronal fitness and activity.